Galmed Pharmaceuticals Ltd. buy BTIG Research
Start price
08.05.24
/
50%
€0.36
Target price
08.05.25
€58.61
Performance (%)
-2.76%
Price
30.05.24
€0.35
Summary
This prediction is currently active. With a performance of -2.76%, the BUY prediction for Galmed Pharmaceuticals Ltd. by BTIG_Research is down slightly. This prediction currently runs until 08.05.25. The prediction end date can be changed by BTIG_Research at any time. BTIG_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Galmed Pharmaceuticals Ltd. | -0.565% |
iShares Core DAX® | -0.552% |
iShares Nasdaq 100 | -1.415% |
iShares Nikkei 225® | -0.877% |
iShares S&P 500 | -0.415% |
Comments by BTIG_Research for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $60.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by BTIG_Research for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.33
29.05.24
29.05.24
€66.36
29.05.25
29.05.25
6.02%
30.05.24
30.05.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.30
18.03.24
18.03.24
€55.09
18.03.25
18.03.25
18.92%
30.05.24
30.05.24